| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0891-5520(05)70326-3 |
| P698 | PubMed publication ID | 8958168 |
| P2093 | author name string | Chanock SJ | |
| Pizzo PA | |||
| P2860 | cites work | Granulocyte transfusion therapy | Q72556080 |
| American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines | Q72816351 | ||
| Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells | Q24339427 | ||
| Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis | Q33494762 | ||
| Human infection with Ehrlichia canis, a leukocytic rickettsia | Q34048684 | ||
| Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis | Q34687030 | ||
| Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy | Q35248092 | ||
| Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). | Q35320608 | ||
| Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients | Q35565163 | ||
| Granulocyte-complement interaction. A beneficial antimicrobial mechanism that can cause disease | Q35620868 | ||
| Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit | Q35714446 | ||
| Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study | Q35836302 | ||
| Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin | Q35900380 | ||
| High-level vancomycin-resistant enterococci causing hospital infections | Q36473265 | ||
| Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule | Q36745761 | ||
| Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. | Q37072813 | ||
| Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients | Q37229872 | ||
| From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever | Q37906806 | ||
| Management of the hematologic complications of human immunodeficiency virus infection | Q37988824 | ||
| Considerations for the prevention of infectious complications in patients with cancer. | Q38241186 | ||
| Aplastic anaemia--aetiology and clinical features | Q38605402 | ||
| Hematopoietic growth factors. Biology and clinical applications | Q38715394 | ||
| Use of routine chest radiography in the evaluation of fever in neutropenic pediatric oncology patients | Q39616132 | ||
| Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia | Q39707323 | ||
| Increasing incidence of Gram-positive sepsis in cancer patients | Q40366767 | ||
| Granulocyte growth factors: achieving a consensus | Q40402490 | ||
| Biologicals and Hematopoietic Cytokines in Prevention or Treatment of Infections in Immunocompromised Hosts | Q40489140 | ||
| Necrotising Enterocolitis Associated with Invasion by Clostridium septicum Complicating Cyclic Neutropaenia | Q40623522 | ||
| Trends in bacterial infections in febrile neutropenic patients: 1986-1992. | Q40643466 | ||
| Predicting the risk of bacteremia in childen with fever and neutropenia | Q40671852 | ||
| Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia | Q40676102 | ||
| Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial | Q40687810 | ||
| Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem | Q40691280 | ||
| Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial | Q40695971 | ||
| Approach to treatment of the febrile cancer patient with low-risk neutropenia. | Q40712373 | ||
| Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer | Q40716793 | ||
| Management of fever in patients with cancer and treatment-induced neutropenia | Q40717836 | ||
| Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy | Q40725458 | ||
| Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death | Q40739507 | ||
| Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone | Q40741794 | ||
| Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis | Q40742943 | ||
| Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer | Q40746556 | ||
| High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms | Q40750001 | ||
| Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient | Q40755877 | ||
| Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation. | Q40774513 | ||
| A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia | Q40805848 | ||
| Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia | Q40806148 | ||
| Approaching the controversies in antibacterial management of cancer patients | Q40828995 | ||
| Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial | Q40840106 | ||
| Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. | Q40844818 | ||
| Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia | Q40845598 | ||
| Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia | Q40847963 | ||
| A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients | Q40870503 | ||
| Clinical presentation of infection in granulocytopenic patients | Q40897081 | ||
| Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia | Q40925796 | ||
| Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. | Q41051200 | ||
| Granulocyte transfusions. Time for a second look | Q41108743 | ||
| Gram-positive bacteraemia in granulocytopenic cancer patients | Q41206758 | ||
| Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges | Q41411269 | ||
| Chronic Neutropenia | Q41513257 | ||
| Alpha-hemolytic streptococci: clinical significance in the cancer patient | Q43488245 | ||
| A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation | Q43619964 | ||
| Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients | Q44125083 | ||
| Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils | Q44241025 | ||
| Anorectal Infections in Patients with Malignant Diseases | Q44319048 | ||
| Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study | Q44604172 | ||
| Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma | Q46922261 | ||
| Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. | Q51196036 | ||
| Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. | Q54171057 | ||
| Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia | Q55061788 | ||
| Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia | Q64132977 | ||
| Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units | Q67469880 | ||
| Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy | Q67973601 | ||
| Hand-washing and nosocomial infections | Q68149975 | ||
| Microbiology of acute periodontal infection in myelosuppressed cancer patients | Q69227838 | ||
| 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection | Q69727619 | ||
| Cytopathology of opportunistic infection in bronchoalveolar lavage | Q69808437 | ||
| New beta-lactam antibiotics in granulocytopenic patients. New options and new questions | Q69903021 | ||
| Natural history of chronic idiopathic neutropenia | Q71147365 | ||
| Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia | Q71722455 | ||
| Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression | Q72032600 | ||
| Exhaustion of mature marrow neutrophils in neonates with sepsis | Q72124897 | ||
| Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis | Q72145908 | ||
| Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same | Q72160665 | ||
| Human ehrlichiosis in the United States, 1985 to 1990 | Q72339224 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 777-796 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Fever in the neutropenic host | |
| P478 | volume | 10 |
| Q24250081 | Colony stimulating factors for prevention of chemotherapy induced febrile neutropenia in children with acute lymphoblastic leukaemia |
| Q24246566 | Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia |
| Q34527650 | Haematopoietic growth factors in children with neutropenia |
| Q49165431 | Hospital-acquired fever in oriental medical hospitals |
| Q34477420 | Infectious diseases in gynecologic oncology: an overview |
| Q49848997 | Neutrophil function in children following allogeneic hematopoietic stem cell transplant |
| Q33599347 | Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea |
Search more.